Work

Development of a Clinically Applicable Method for High-Efficiency Gene Correction of Plerixafor-Mobilized CD34+ Cells from Patients with Sickle Cell Disease

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-111677

Authors: Naoya Uchida, Linhong Li, Juan J Haro-Mora, Selami Demirci, Tina Nassehi, Jackson Gamer, Claire Drysdale, Morgan Yapundich, Cornell Allen, Suk See De Ravin, Harry L Malech, Madhusudan Peshwa, John F. Tisdale

Institutions: National Institutes of Health, National Heart, Lung, and Blood Institute, MaxCyte (United States), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases

Language: English

Topic: CRISPR and Genetic Engineering

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2907667499

Cites:

Cited by: 4

Related to: 10